{"id":"W2087587748","doi":"10.1056/nejmoa044537","title":"Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1389,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"","keywords":"Rimonabant; Medicine; Overweight; Dyslipidemia; Placebo; Internal medicine; Body mass index; Weight loss; Endocrinology; Waist; Obesity; Cannabinoid receptor; Antagonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006164660330615556,"score_gpt":0.257506606453006,"score_spread":0.2513419461223905,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}